Crinetics Pharmaceuticals (CRNX) Cash on Hand
Market Cap: $2.71B
Avg Volume: 1.08M
Industry: Biotechnology
Sector: Healthcare
How much cash does Crinetics Pharmaceuticals have?
According to Crinetics Pharmaceuticals's latest annual financial reports, the company has a total of $264.55M in cash and cash equivalents. This amount includes all liquid assets that can be readily converted into cash.
Additionally, Crinetics Pharmaceuticals holds $1.09B in short-term investments, which are highly liquid assets that can be easily converted into cash within a short period.
In total, the company has $1.35B when combining cash and cash equivalents with short-term investments.
On a per-share basis, Crinetics Pharmaceuticals has $16.76 in cash. This metric helps investors understand how much cash the company holds per outstanding share.
The company's free cash flow, which is the cash generated from operations after deducting capital expenditures, stands at $-229.81M. This is an important indicator of financial health, showing the cash available for distribution to shareholders or reinvestment into the company.
Lastly, the company's cash position has experienced a growth rate of 381.89%, reflecting the increase in cash and cash equivalents over the specified period.
Cash & Cash Equivalents
$264.55M
Short-Term Investments
$1.09B
Cash & Short-Term Investments
$1.35B
Cash Per Share
$16.76
Free Cash Flow
$-229.81M
Cash Growth
381.89%
Crinetics Pharmaceuticals Historical Cash on Hand
Cash on Hand History
The table below shows the amount of cash on hand for each year, with the latest data available for the last fiscal year 2024.
| Year | Cash on Hand | Change |
|---|---|---|
| 2024 | $264.55M | 381.89% |
| 2023 | $54.90M | 68.02% |
| 2022 | $32.67M | -83.72% |
| 2021 | $200.69M | 115.60% |
| 2020 | $93.09M | 130.84% |
| 2019 | $40.33M | -10.33% |
| 2018 | $44.97M | 216.89% |
| 2017 | $14.19M | 16.79% |
| 2016 | $12.15M | N/A |
Related Metrics
Explore detailed financial metrics and analysis for CRNX.